Image

Donor Site Morbidity and Buccinator Muscle Integrity After Buccinator Myomucosal Flap Surgery in Patients With Velopharyngeal Incompetence

Donor Site Morbidity and Buccinator Muscle Integrity After Buccinator Myomucosal Flap Surgery in Patients With Velopharyngeal Incompetence

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The aim of this study is to evaluate donor site morbidity and buccinator muscle integrity following the use of buccinator myomucosa flap in patients with velopharyngeal incompetence.

Description

Cleft lip and palate represent one of the most common congenital deformities. The associated disruption of palatal structure leads to abnormal velopharyngeal anatomy, frequently resulting in failure to achieve adequate closure of the velopharyngeal valve even after primary palatal repair.

Buccal artery myomucosal flap Firstly described by Bozola this axial-pattern flap is based on and centered around the buccal artery, a branch of the internal maxillary artery. The flap extends from the maxillary tuberosity to the oral commissure and is primarily used for the closure of mucosal defects involving the posterior hard palate, soft palate, and maxillary alveolus.

Eligibility

Inclusion Criteria:

  • Patients diagnosed with velopharyngeal incompetence undergoing palatal lengthening using bilateral posteriorly based buccinator myomucosal flaps.
  • Non-syndromic patients.

Exclusion Criteria:

  • Syndromic cleft patients with associated neuromuscular disorders.
  • History of previous cheek surgery affecting the buccinator muscle.
  • Patients who declined participation in the study.

Study details
    Donor Site
    Morbidity
    Buccinator Muscle
    Integrity
    Buccinator Myomucosal Flap Surgery
    Velopharyngeal Incompetence

NCT07853872

Sohag University

21 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.